Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meghan C Tveit

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Sexual Medicine|February 10, 2025
Glucagon-like peptide-1 agonist weight loss medications decrease sexual desire: a theoretical framework based in the serotonergic pathwayMeghan C Tveit, Sonya T Gelfand, James A Simon
Obesity Pillars|December 17, 2025
Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' itSonya T Gelfand, Meghan C Tveit, James A Simon
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Sexual Medicine|February 10, 2025
Glucagon-like peptide-1 agonist weight loss medications decrease sexual desire: a theoretical framework based in the serotonergic pathwayMeghan C Tveit, Sonya T Gelfand, James A Simon
Obesity Pillars|December 17, 2025
Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' itSonya T Gelfand, Meghan C Tveit, James A Simon
Pageof 1